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Abstract DsbA proteins, the primary catalysts of protein
disulﬁde bond formation, are known to aﬀect virulence
and penicillin resistance in Gram-negative bacteria. We
identiﬁed a putative DsbA homologue in the Gram-
positive pathogen Staphylococcus aureus that was able to
restore the motility phenotype of an Escherichia coli
dsbA mutant and thus demonstrated a functional thiol
oxidoreductase activity. The staphylococcal DsbA
(SaDsbA) had a strong oxidative redox potential of
131 mV. The persistence of the protein throughout the
growth cycle despite its predominant transcription dur-
ing exponential growth phase suggested a rather long
half-life for the SaDsbA. SaDsbA was found to be a
membrane localised lipoprotein, supporting a role in
disulﬁde bond formation. But so far, neither in vitro nor
in vivo phenotype could be identiﬁed in a staphylococcal
dsbA mutant, leaving its physiological role unknown.
The inability of SaDsbA to interact with the E. coli
DsbB and the lack of an apparent staphylococcal DsbB
homologue suggest an alternative re-oxidation pathway
for the SaDsbA.
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Introduction
Disulﬁde bonds between cysteine residues support the
correct folding of proteins and maintain their structural
integrity and activity. Disulﬁde bond containing pro-
teins are usually localised in extracytoplasmic compart-
ments or secreted into the medium, but are rare in the
reducing environment of the cytoplasm. Although
disulﬁde formation can occur spontaneously under oxi-
dising conditions, this reaction is unspeciﬁc and slow
(Anﬁnsen 1973). In vivo, enzymatic systems ensure eﬃ-
cient and correct disulﬁde bond formation. The primary
catalyst of this reaction in Escherichia coli is the exten-
sively studied periplasmic thiol-disulﬁde oxidoreductase
DsbA. It is a monomeric 21-kDa protein containing a
redox active C-X-X-C sequence embedded in a thiore-
doxin fold, typical for the proteins of this family
(reviewed in Kadokura et al. 2003). Upon catalysing
disulﬁde bond formation, the two cysteines of DsbA
become reduced and are subsequently re-oxidised by the
inner membrane protein DsbB, which passes the elec-
trons to the electron transfer chain via quinone reduc-
tion (Guilhot et al. 1995; Kishigami et al. 1995;
Kishigami and Ito 1996; Bader et al. 1998, 1999).
Escherichia coli dsbA mutants have a pleiotropic
phenotype and, amongst others, lack motility due to the
improper assembly of the ﬂagellar motor (Jones et al.
1990; Dailey and Berg 1993). Interestingly, dsbA mu-
tants of several Gram-negative pathogenic bacteria also
exhibit a reduced virulence, due to the absence of critical
disulﬁde bonds in exotoxins, adherence factors or pili
(Yu and Kroll 1999; Yu et al. 2001; Stenson and Weiss
2002; Ha et al. 2003; Burall et al. 2004; Miki et al. 2004).
So far, an involvement of a DsbA homologue in viru-
lence of a Gram-positive pathogen has not been docu-
mented.
In Gram-negative bacteria, disulﬁde bond formation
occurs in the periplasm. Gram-positive bacteria do not
possess a classic periplasmic compartment, and very
little is known about disulﬁde bond formation in these
organisms. The Bacillus brevis Bdb was the ﬁrst DsbA
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homologue of a Gram-positive bacterium shown to have
thiol oxidase activity by complementing the motility of
an E. coli dsbA mutant (Ishihara et al. 1995). Subse-
quently, the Bacillus subtilis BdbC and BdbD were
demonstrated to be functional homologues of the E. coli
DsbA and DsbB, respectively, and to be involved in the
development of competence (Erlendsson and Hederstedt
2002; Meima et al. 2002). Although some of the secreted
virulence factors produced by the human pathogen
Staphylococcus aureus, such as all staphylococcal en-
terotoxins and the beta-haemolysin, are known to con-
tain disulﬁde bonds in their active forms (Hovde et al.
Table 1 Bacterial strains and
plasmids
aa amino acids
Relevant properties Source or reference
Strains
Escherichia coli
Rosetta DE3 BL21 derivative Novagen
AD13 JCB571, pAD2 This study
AD15 JCB571, pBR322 This study
AD28 JCB571, pAD11 This study
AD29 JCB571, pISC2 This study
AD44 Rosetta DE3, pmSaDsbA, Apr
AD59 JCB818, pAD2, Kmr, Apr This study
AD60 JCB818, pAD11, Kmr, Apr This study
AD189 JCB818, pBR322, Kmr, Apr This study
AD190 JCB818, pEC52, Kmr, Apr This study
AD191 JCB570, pBR322, Kmr, Apr This study
JCB570 MC1000 phoR zih12::Tn 10 Bardwell et al. 1991
JCB571 JCB570 dsbA::kan1 Bardwell et al. 1991
JCB818 MC1000 dsbA::kan1, dsbB::kan, Kmr Jonda et al. 1999
Staphylococcus aureus
8325-4 NCTC8325 derivative, cured of all prophages Peng et al. 1988
AD19 RN4220 dsbA::tet; Tcr This study
AD21 BB270 dsbA::tetL; Tcr, methicillin resistant (Mcr) This study
AD22 Newman dsbA::tetL; Tcr This study
AD23 MSSA1112 dsbA::tetL; Tcr This study
AD188 8325-4 dsbA::tetL; Tcr This study
BB270 NCTC8325 mec; Mcr Berger-Ba¨chi and
Kohler 1983
MB261 BB270 (dsbAp::luc+)-pBT This study
Newman ATCC 25904, clinical isolate Duthie and
Lorenz 1952
RN4220 8325-4; restriction negative Rhoads Kraemer
and Iandolo 1990
Plasmids
pAD2 pBR322 derivative; containing a 1.4 kb
fragment of S. aureus BB270 encoding SA2198
and dsbA; Tcr, Apr
This study
pAD7 pEC4 derivative ; containing the double crossover
construct for the inactivation of dsbA in S. aureus;
Tcr ; Emr ; Apr
pAD11 pISC2 derivative; containing the sequence for a
translational fusion of the OmpA signal peptide
and the truncated (aa 19-199) DsbA of S. aureus
under the control of an arabinose inducible
promoter; Apr
This study
pBR322 E. coli cloning vector; Tcr, Apr Bolivar et al. 1977
pBT S. aureus suicide vector; containing the tetL gene;
Tcr
Giachino et al. 2001
pBT dsbA::luc+ pBT with 1 kb PCR fragment of the dsbA
promoter from strain BB270 fused to the
luciferase gene luc+; Tcr
This study
pEC4 Suicide vector ; containing the tetL gene; Tcr Bru¨ckner 1997
pEC52 pISC2 derivative; containing the sequence for a
translational fusion of the OmpA signal peptide
and the truncated CcmG of E. coli under the
control of an arabinose inducible promoter; Apr
Fabianek et al. 1998
pET11a E. coli cloning vector; Apr Novagen
pISC2 E. coli expression vector; Apr Tho¨ny-Meyer et al. 1998
pmSaDsbA pET11a derivative; encoding a truncated DsbA
without signal sequence; Apr
This study
pSP- luc+ Fireﬂy luciferase cassette vector; Apr Promega
pSP- dsbA::luc+ 1 kb PCR fragment of dsbA promoter from strain
BB270 in pSP- luc+; Apr
This study
118
1994; Dziewanowska et al. 1996), the mechanism by
which these disulﬁde bonds are formed has never been
examined. In this study we describe the identiﬁcation
and functional characterisation of a putative DsbA
homologue (SA2197) in S. aureus and analyse its
importance for virulence and antibiotic resistance.
Materials and Methods
Bacterial strains, plasmids, and media
The strains and plasmids used in this study are listed in
Table 1. The cells were grown at 37C in Luria-Bertani
(LB) medium. When required, tetracycline 10 lg/ml, or
ampicillin 100 lg/ml were added.
DNA manipulations
Preparation of chromosomal and plasmid DNA, PCR,
and Southern blot analysis were performed by standard
procedures (Sambrook et al. 1989). Probes were labelled
with the PCR DIG Probe Synthesis Kit (Roche, Rotk-
reuz, CH, USA), following the manufacturer’s instruc-
tions. Transductions were done with phage 80a as
described previously (Berger-Ba¨chi 1983). Primers used
for PCR, sequencing and primer extension reactions are
listed in Table 2.
Sequence analysis
Direct chromosomal sequencing of the SA2198- dsbA
operon of strain BB270 was done according to the
protocol of A. Wada (Wada 2001) on a ABI Prism 310
Sequencer (Perkin Elmer) with the primers Seq1, Seq2,
Seq3, Seq4 and PEX2. The sequences were compared to
genome sequences of S. aureus NCTC8325
(NC_002954), Mu50 (NC_002758), N315 (NC_002745),
MW2 (NC_003923) (Kuroda et al. 2001), COL (TIGR),
MSSA476 (NC_002953) and MRSA252 (NC_002952).
Homology searches were performed using the program
BLAST (http://www.ncbi.nlm.nih.gov/BLAST) (Altsc-
hul et al. 1990). The sequence was deposited in GenBank
under the accession number AF321274.
Isolation and analysis of total RNA
Total RNA was isolated according to the protocol of
Cheung (Cheung et al. 1994), using the FastRNA kit
(BIO 101, Vista, CA, USA). Northern blot analysis was
performed as described by Sambrook (Sambrook et al.
1989). The transcriptional start was determined by pri-
mer extension using the 32 P-labeled primers PEX1,
PEX2 and PEX3 as described by Rossi (2003).
dsbA promoter-reporter gene construct
A 1 kb DNA fragment covering the SA2198-dsbA pro-
moter region (dsbAp) of S. aureus was ampliﬁed using
the primers DsbApf and DsbApr, digested with KpnI
and NcoI and cloned in front of the luciferase gene of
plasmid pSP- luc+. A 2.6 kb KpnI-EcoRI fragment,
including the dsbA promoter region fused to the lucif-
erase coding region was subsequently subcloned into
suicide plasmid pBT (Giachino et al. 2001) yielding
plasmid pBT dsbAp::luc+, which was electroporated
into RN4220. A co-integrate was selected and used as a
donor to transduce strain BB270, resulting in strain
MB261. The luciferase activity was measured as de-
scribed earlier (Bischoﬀ et al. 2001).
Table 2 Primers
1The recognition sites of restri-
ction enzymes are underlined
2The indicated position is rela-
tive to the ﬁrst nucleotide of
dsbA
Primers Sequences 5¢ - 3¢1 Position of
the 3¢ end2
Restriction
site
Seq1 catgatgcggattatcatg 38
Seq2 ctgcatgactcgcacgcgaacc 253
Seq3 ctcgtacaattaaaattgtc 33
Seq4 gctataatagttgttgtact 71
Pr1f gggaattcatgtttgacggtgtatag 431 EcoRI
Pr1r ggaagcttacttttgtcataagtgcc 914 HindIII
PEX1 taatgttagtaattttttagtc 3
PEX2 atcaccgttgccttttttgg 256
PEX3 cacaaatcgcttcaatgctc 385
DsbApf gaggtaccaatttcaccgtctgcattgcg 977 Asp718
DsbApr tagccatggtaactcctgttcatatctagttcg 26 KpnI
SaDsbAf cctagctagcatgcatcaccatcaccaccatggtaaaaaagaatcagcaacgacatcc 84 NheI
SaDsbAr ccgcggatccctattttattttatcttttaataacttctcataactttc 525 BamHI
Pr3f cagaggcctcaaaaaaagaatcagcaacg 78 StuI
Pr3r cgggaattcgaagaatcaatacctatcctg 755 EcoRI
Pr4f cgaaaagtgccacctgacg
Pr4r aactaatggtttgccgtttttc 88
TetL + ccatattgttgtataagtg
TetL  cctgttataaaaaaaggatc
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SaDsbA-isolation and antibody preparation
The primers SaDsbAf and SaDsbAr were used to amplify
a fragment encoding the presumed mature part of SaD-
sbA lacking its signal sequence (mSaDsbA). The fragment
was cloned into pET11a using NheI and BamHI
restriction sites. The cloning procedure did add four
supplementary amino acids M-A-S-M to the N-terminus
of mSaDsbA, thereby introducing a new start methionine
to the mSaDsbA. The resulting plasmid pmSaDsbA was
transformed into Rosetta DE3 cells (Novagen) for
overexpression. Cells were grown in LB medium to an
OD600 of 0.8 and induced with 1 mM IPTG. After 3 h,
cells were collected by centrifugation and resuspended in
20 mM Tris/HCl pH 8.0. The cells were disrupted (Cell
Cracker, EMBL, Heidelberg Germany), and the debris
separated by centrifugation for 30 min at 15,000 g. The
supernatant was applied onto a QA-52 anion-exchange
column (Whatman, Brentfort, UK) pre-equilibrated with
20 mM Tris/HCl pH 8.0. Proteins were eluted with a 0–
1 M gradient of NaCl in 20 mM Tris/HCl pH 8.0. Frac-
tions containing mSaDsbA were pooled, dialysed against
20 mM HEPES/NaOH pH 8.0 and applied onto a SE52
cation-exchange column (Whatman). mSaDsbA was
eluted with a gradient of 0–1 MNaCl in 20 mMHEPES/
NaOH pH 8.0. One milligram of the eluted, homogenous
mSaDsbAwas used to raise chicken antibodies (DAVIDS
Biotechnologie, Regensburg, Germany).
Fluorescence spectroscopy and determination
of the redox potential
The redox potential of mSaDsbA was determined
essentially as previously described (Grauschopf et al.
2003) by measuring the redox equilibrium of mSaDsbA
with glutathione using a speciﬁc ﬂuorescence intensity
change at 327 nm between the oxidised and reduced
state of the protein.
Localisation of SaDsbA
Exponentially growing Newman cells harvested at
OD600 2 were disrupted and fractionated into superna-
tant, cell wall, cell membrane and cytoplasm, according
to Schneewind (1993). Protein fractions corresponding
to a 1-ml culture were subjected to Western analysis
using antigen-puriﬁed anti-DsbA antibodies at a dilu-
tion of 1:5,000. To demonstrate the lipoprotein nature of
SaDsbA, growing cells were challenged with 50 lg/ml
globomycin (Sankyo Corp., Tokyo, Japan) at OD600 0.4
and harvested at OD600 2. Aliquots containing 15 lg
whole protein were subjected to Western blot analysis
using the conditions given above.
Complementation of an E. coli dsbA mutant by the dsbA
gene of S. aureus
A 1.4-kb fragment covering the SA2198- dsbA operon as
well as the SA2198- dsbA promoter was ampliﬁed using
the primers Pr1f and Pr1r. The obtained insert was
cloned into the EcoRV site of pBR322, yielding pAD2.
Plasmid pAD11, carrying a translational in-frame fusion
of the E. coli OmpA signal peptide, MKKTAIAIAVA-
LAGFATVAQA, with the putative mature part of
SaDsbA (aa 19–199) was constructed by amplifying a
735-bp fragment encoding an SaDsbA lacking its 18 N-
terminal amino acids with the primers Pr3f and Pr3r,
and cloning it into the StuI-EcoRI restricted pEC52
(Fabianek et al. 1998). In this construct the codons for
cysteine 19 and glycine 20 were changed to codons for
alanine and serine, respectively, thereby eliminating the
signal peptidase II recognition site of SaDsbA.
To determine the complementation of the non-motile
E. coli dsbA mutant strain JBC571 (Bardwell et al.
1991), plasmids pAD2, pAD11 as well as the empty
vectors pBR322 and pISC2 were electroporated into E.
coli JCB571. The motility of the resulting strains AD13,
AD28, AD15 and AD29, respectively, was tested by
placing ﬁlter discs of 6 mm diameter (bioMe´rieux)
soaked in the respective overnight cultures, onto an LB
plate containing 0.3% agar and 0.2% arabinose and
incubating for 12.5 h at 37C. To test the dependence of
the complementation on the presence of DsbB, plasmids
pAD2, pAD11, pBR322 and pISC2 were electroporated
into the E. coli dsbA dsbB double mutant JCB818,
yielding strains AD59, AD60, AD189 and AD190,
respectively. As a control, pBR322 was electroporated
into the wild-type strain JCB570, yielding AD191. The
dependence of the complementation of the dsbA and
dsbA dsbB mutants on the presence of cystine was
demonstrated by growing the strains overnight in liquid
M9 medium containing 4 lg/ml of each amino acids
except cysteine, 0.4% glycerol and 100 lg/ml ampicillin.
Thirty microlitre of the overnight culture, resuspended
to an OD600 of 0.2, were placed on 6 mm ﬁlter discs
which were transferred to an M9 agar plate containing
0.3% agar, 0.2% arabinose and 4 lg/ml of each amino
acid except cysteine. When required, 25 lg/ml cystine
was added to the medium. The distance reached by
motile swarming cells was determined after overnight
incubation.
Insertional inactivation of dsbA
The dsbA gene from S. aureus was inactivated by
replacing a 249 bp internal fragment with a 1.6-kb tetL
cassette. An 845-bp fragment upstream of dsbA was
ampliﬁed using pAD2 as a template and the primers Pr4f
and Pr4r, digested with EcoRI, and inserted into the 4.7-
kb fragment EcoRI-HpaI fragment of pAD2. The three
bases GTT at the 3’-end of the insert restored an HpaI
site after ligation with the vector. The 1.6-kb tetL frag-
ment was ampliﬁed by PCR from plasmid pBT using the
primers TetL+ and TetL- and inserted into the restored
HpaI site. From this product the 2.7-kb EcoRI–BamHI
fragment was excised and inserted into the correspond-
ing sites of pEC4, yielding plasmid pAD7. Tetracycline
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resistant clones obtained after electroporation of pAD7
into the S. aureus RN4220 were screened for loss of
erythromycin resistance. About 5% of the tetracycline
resistant clones were sensitive to erythromycin, indicat-
ing loss of the plasmid backbone due to a double
crossover. The dsbA::tetL allele of the resulting strain
AD19 was transferred to strains BB270, Newman,
MSSA112, and 8325-4 by phage transduction, resulting
in strains AD21, AD22, AD23, and AD188 respectively.
The deletion of the dsbA fragment on the chromosome
was conﬁrmed by Southern blot analysis.
Characterisation of the S. aureus dsbA mutant
Susceptibility to dithiothreitol (DTT) was tested by
placing sterile ﬁlter discs of 6 mm diameter impregnated
with 20 ll of a 1 M DTT on a lawn of cells diluted to
McFarland 0.5 in 0.8% NaCl and spread on Mu¨ller-
Hinton plates. The inhibition zone was measured after
overnight incubation at 37 C. Susceptibility to antibi-
otics was assessed by E-test (AB Biodisk, Solna, Swe-
den) following the recommendations of the
manufacturer. The relative resistance to oxacillin of the
strain pair BB270/AD21 was compared on plates con-
taining a gradient of oxacillin from 0 to 200 lg/ml.
Measurement of the haemolytic activity
The haemolytic activities of strain 8325-4 and its dsbA
defective derivative AD188 were essentially determined
following the protocol of Nilsson and co-workers
(Nilsson et al. 1997). After incubation of the washed
erythrocytes with diluted culture supernatant, the sam-
ples were centrifuged for 1 min at 7000 g. The optical
density at 415 nm due to the released haemoglobin was
measured and plotted against the dilution factor of the
culture supernatant.
Animal models
Strain Newman and its dsbA mutant AD22 were used
in two pathogenicity assays. The Caenorhabditis
elegans killing assay was performed according to the
protocol by Sifri and co-workers (Sifri et al. 2003). In
the mouse model for septic arthritis, the protocol
described by Bremell and co-workers (Bremell et al.
1991) was followed, using 15 mice and a bacterial load
of 6·106 cells.
Results
Identiﬁcation of a putative DsbA homologue
B. subtilis BdbD was previously identiﬁed as a close
E. coli DsbA homologue in a Gram-positive organism
(Fabianek et al. 2000). A BLAST search for Bdb
homologues in the S. aureus NCTC8325 genome
database resulted in the identiﬁcation of a 199-amino
acid ORF with 41% similarity to BdbD that was
tentatively termed SaDsbA. No further Dsb or Bdb
homologues were found in any of the published gen-
ome sequences of S. aureus. Direct chromosomal
sequencing of the NCTC8325 derivative BB270 over
the region covering dsbA showed an exact match with
the corresponding published genome sequences of
NCTC8325 and COL. In S. aureus MW2, Mu50,
N315, MRSA252 and MSSA476, a G to A transition
causes the valine residue at position 38 to be changed
to a isoleucine. In addition, a G to T transversion
causes the change of leucine at position 52 to a
phenylalanine in strain MRSA252.
The deduced sequence of the 20 N-terminal amino
acids of the S. aureus DsbA revealed the characteristics
of a lipoprotein signal sequence with an ILTACG pre-
dicted signal peptidase II cleavage site (PROSITE mo-
tive PS00013) (Tjalsma et al. 2000; Sutcliﬀe and
Harrington 2002), suggesting SaDsbA to be an ex-
tracytoplasmic lipoprotein with a lipid attachment site at
cysteine 19.
The predicted size of 181 aa of the deduced mature
SaDsbA was similar to that of DsbA from other bac-
teria, and conserved residues were found over the entire
length of its primary structure (Fig. 1). SaDsbA har-
bours, with its C-P-Y-C motif, the C-X-X-C active site
characteristic for thiol-disulﬁde oxidoreductases, and
possesses a proline residue at position 154, which aligns
well with the cis-proline at position 151 of E. coli DsbA
(Fig. 1). The cis-proline, strongly conserved in all
members of the thioredoxin family, and positioned close
to the C-X-X-C motif in their native form (Martin
1995), has a critical role in the resolution of the mixed
disulﬁde intermediate (Kadokura et al. 2004) and aﬀects
the stability of DsbA proteins (Charbonnier et al. 1999).
Upstream of the S. aureus dsbA, and separated by 21
nucleotides, a 360-bp open reading frame (ORF),
SA2198, was identiﬁed. This ORF encodes a putative
protein of 120 amino acids that shares no apparent
similarity to any other protein with known function.
SA2198 appears to have a lipoprotein signal sequence
with a FISGCG predicted signal peptidase II cleavage
site. The sequence of this ORF was found to be identical
in all the published S. aureus genome sequences, sug-
gesting that its gene product is functional in S. aureus.
Additionally, a similar genetic organisation was found in
the closely related Staphylococcus epidermidis, with the
two predicted lipoproteins, SE1987 sharing 68% se-
quence similarity with SaDsbA, and SE1988 sharing
65% similarity with SA2198.
Analysis of the dsbA transcript
Northern blot analyses with probes covering either dsbA
or SA2198- dsbA, yielded a single 1.3-kb transcript
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(Fig. 2a), indicating that SA2198 and dsbA are co-
transcribed, thereby forming a bi-cistronic operon. The
level of the 1.3-kb transcript was high during early
exponential growth (30 min to 2 h) and strongly de-
creased thereafter (3 and 5 h). A dsbA promoter-lucif-
erase reporter gene fusion, co-integrated into the S.
aureus chromosome of strain MB261, conﬁrmed the
growth phase-dependent expression pattern of SA2198-
dsbA (Fig. 2b). Western blot analysis, however, dem-
onstrated SaDsbA to be present at all time points
analysed, irrespective of the transcription pattern of its
gene (Fig. 2c).
Primer extension experiments, using primers binding
either within dsbA or SA2198 coding sequences, yielded
one transcriptional start point 42 bp upstream of SA2198
(Fig. 3), conﬁrming the co-expression of these two genes.
The identiﬁed transcriptional start point is preceded by a
sequence (TTGTAG20-TATAGT), which is fairly well
resembling the consensus promoter sequence of the
house-keeping rA factor (TTGACA16–18-TATAAT)
(Helmann 1995; Rao et al. 1995), with the predicted 35
and 10 regions being separated, however, by an
unusually long spacer region of 20 nucleotides.
Production of SaDsbA in E. coli and determination of
its redox potential
We produced the predicted mature part of SaDsbA in
the cytoplasm of E. coli strain AD44 containing plasmid
pmSaDsbA. After the two-step puriﬁcation using an
anion-exchange and a cation-exchange column, 80 mg
of pure mSaDsbA were obtained from an original 6 l
culture. We found that oxidised mSaDsbA, similarly
to its E. coli homologue exhibited an increase in
tryptophane ﬂuorescence at 327 nm upon reduction of
the disulﬁde bond by dithiothreitol. We made use of this
redox-state-dependent ﬂuorescence to determine the
intrinsic redox potential of mSaDsbA. By equilibrating
the protein with diﬀerent glutathione redox buﬀers, a
Fig. 2 Expression pattern of dsbA transcript during growth.
A Northern blot analyses of dsbA expression in strain BB270
using a DIG-labelled DNA-probe speciﬁc for SA2198 and dsbA.
B The transcriptional activity of the dsbA promoter was determined
by measuring the luciferase activity of a dsbA::luc+ fusion (open
symbols). Bacterial growth was measured as the OD600 (solid
symbols). C Detection of SaDsbA by Western blot analysis. Fifteen
micrograms obtained from whole-cell extracts were loaded in each
lane
Fig. 1 Alignment of the conserved active site and of the cis-proline
region of some members of the DsbA protein family. The
alignment was performed with the program ClustalW (Thompson
et al. 1994) using the default parameters. Identical residues are
underlayed in black. Dark grey and grey shaded residues correspond
to conserved and semi-conserved substitutions, respectively. 1 The
position indicated refers to the ﬁrst aa in the alignment of the
mature protein. The position of the cleavage site was predicted by
the program SignalP using the standard parameters (Bendtsen
et al. 2004). 2 The indicated length refers to the mature protein.
Sequences shown are from S. aureus, S. epidermidis, B. subtilis,
Bacillus anthracis, Neisseria meningitidis, E. coli, Salmonella
typhimurium, Yersinia pestis, Haemophilus inﬂuenzae, Vibrio chole-
rae and Pseudomonas aeruginosa
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single transition with an equilibrium constant (Keq) of
2.09±0.27·104 M was detected, corresponding to a
redox potential (E’o) of 131 mV (Fig. 4). Thiol-disul-
ﬁde oxidoreductases of the thioredoxin family have re-
dox potentials ranging from 270 mV for the E. coli
thioredoxin to 122 mV for the most oxidative of all,
the E. coli DsbA.
Localisation of SaDsbA
To conﬁrm that SaDsbA is a lipoprotein, cells of
strain Newman were fractionated into cell wall, cell
membrane and cytoplasm. The fractions were sub-
jected to Western blot analysis using polyclonal anti-
bodies raised against the puriﬁed SaDsbA. An antigen
corresponding to the expected size of 21.0 kDa was
detected exclusively in the membrane fraction (Fig. 5).
Additionally, no SaDsbA was detected among TCA
precipitated proteins obtained from the culture
supernatant. In order to conﬁrm the lipoprotein
character of SaDsbA, we challenged exponentially
growing cells of strain Newman with globomycin, an
antibiotic which inhibits the cleavage of the lipopro-
tein signal sequence by blocking signal peptidase II,
resulting in the accumulation of an unprocessed form
of the protein that typically runs 2–3 kDa higher than
the mature lipoprotein (Inukai et al. 1984). This spe-
ciﬁc eﬀect of globomycin has been previously used for
analysis of lipoprotein maturation in S. aureus
(Navarre et al. 1996). Protein extracts from cells
treated with globomycin contained a second band
running at a slightly higher molecular weight, as ex-
pected for the unprocessed SaDsbA (Fig. 6).
Complementation of an E coli dsbA mutant
E. coli dsbA mutants are impaired in motility due to
their inability to form the disulﬁde-bond of the ﬂa-
gellar protein FlgI (Jones et al. 1990; Dailey and Berg
1993). This phenotype has been used to identify genes
Fig. 5 Subcellular localisation of SaDsbA. Cells of strain Newman
were fractionated in cell wall (cw), cell membrane (mem) and
cytoplasmic (cyto) fractions. As control, 30 ng of puriﬁed mature
staphylococcal DsbA (mSaDsbA) was loaded. The protein fractions
were separated on a 12% SDS-PA gel and analysed by Western
blotting using the anti-DsbA antibody. The amount of protein of
each fraction corresponded to a 1-ml culture
Fig. 4 Redox equilibrium of SaDsbA with glutathione. SaDsbA
was incubated in the presence of 1 mM GSSG and varying
concentrations of GSH in 100 mM sodium phosphate, pH 7.0 at
25 C. The tryptophane ﬂuorescence at 327 nm was recorded, and
data were ﬁtted as described (Grauschopf et al. 2003)
Fig. 3 Determination of the transcription start site of the SA2198 -
dsbA transcript by primer extension. The signal detected using the
c32 P labelled primer PEX3 is designated by an arrow. The same
start site was obtained with the primers PEX1 and PEX2 (data not
shown). The portion of the sequence represented in the picture is
written in italics. The 10 region, the mapped transcriptional start,
the ribosome binding site and the ﬁrst amino acids of SA2198 are
indicated
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that complement dsbA mutants (Ishihara et al. 1995;
Ng et al. 1997). To demonstrate the functionality of
SaDsbA, we complemented the E. coli dsbA mutant
strain JCB571 with plasmid pAD2, containing SA2198
-dsbA. This construct clearly restored the motility of
the dsbA mutant, although not to wild-type levels,
whereas complementation with the empty plasmid
pBR322, had no eﬀect on motility of the mutant
(Fig. 7). To exclude that the eﬃciency of complemen-
tation was impaired because of incompatibilities of the
staphylococcal gene at the transcriptional or export
level in E. coli, we complemented JCB571 with plasmid
pAD11, harbouring a sequence encoding a chimeric
protein where the signal sequence of the E. coli outer
membrane protein OmpA was fused to the predicted
mature part of SaDsbA. Complementation of the dsbA
mutant with pAD11 restored the motility of JBC571 in
a way that was almost identical to that obtained with
pAD2 (Fig. 7). In order to assess whether the activity
of SaDsbA in the E. coli mutant was dependent on the
presence of E. coli DsbB, the motility of an E. coli
dsbA dsbB double mutant was tested in a similar way.
Since it is known that cystine, a di-amino acid result-
ing from the oxidation of cysteine, can functionally
complement a dsbB mutant (Dailey and Berg 1993),
the motility tests were performed on an M9-based
swarm agar devoid of cysteine. On this medium, none
of the plasmids encoding the S. aureus DsbA were able
to complement either the dsbA dsbB double mutant
(Fig. 8), or the dsbA single mutant (not shown). When
the swarm agar was supplemented with 25 lM cystine,
the strains containing pAD2 or pAD11 partially re-
stored motility of both the single and the double
mutant (Fig. 8).
Inactivation of dsbA in S. aureus
In order to analyse the function of dsbA in S. aureus, a
dsbA mutant was constructed by replacing an internal
249-bp dsbA fragment with a tetL resistance cassette.
The dsbA deﬁcient strains were not impaired in aerobic
growth. Since dsbA mutants of E. coli have been shown
to have an increased sensitivity to reduced dithiothreitol
(DTT) (Missiakas et al. 1993), we tested the S. aureus
mutant strains for growth inhibition by this substance.
The sensitivities of strains AD21, AD22 and AD23 to
this substance were the same as those of the respective
wild types (data not shown). Another reported
phenotype of E. coli dsbA is a reduced resistance to the
b-lactam antibiotic benzylpenicillin (Missiakas et al.
1993). Since many proteins of S. aureus involved in
resistance to antibiotics contain cysteine residues that
might form disulﬁde bonds, we tested the resistance of
the S. aureus mutants to various antibiotics using E test
or antibiotic gradient plates. The tested antibiotics be-
longed to various classes, targeting cell wall biosynthesis
(beta-lactams and glycopeptides), protein synthesis
(aminoglycosides, lincosamides, macrolides), DNA gyr-
ase activity (ﬂuorochinolones) or RNA synthesis (rif-
ampicin). However, no signiﬁcant diﬀerence could be
seen between wild-type and dsbA mutant strains with
respect to the resistance levels of all antibiotics analysed
(data not shown).
The S. aureus beta-haemolysin, also termed sphin-
gomyelinase C, requires a disulﬁde bond for activity
Fig. 7 Complementation of the motility of an E. coli dsbA mutant.
Partial restoration of the E. coli dsbA deﬁcient strain JCB571 by the
staphylococcal DsbA, alone (pAD11) and in combination with
SA2198 (pAD2)
Fig. 6 Inﬂuence of globomycin on the maturation of DsbA.
Bacterial cultures were treated with 0 or 50 lg/ml globomycin,
respectively. Fifteen micrograms of proteins from whole-cell
extracts were analysed by Western blotting using the anti-DsbA
antibody. As control, 30 ng of the puriﬁed (mSaDsbA) was loaded
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(Dziewanowska et al. 1996). We therefore compared the
appearances and diameters of the beta-haemolysis-zones
of the dsbA defective strains AD19, AD21, AD22 and
AD23 and their respective parental strains RN4220,
BB270, Newman and MSSA1112 on sheep blood agar
plates, but were unable to observe notable diﬀerences.
Similarly, no signiﬁcant diﬀerences were found in the
release of haemoglobin from sheep blood cells chal-
lenged with supernatants from stationary phase cultures
of the beta-haemolysin producing strain 8325-4 or its
corresponding dsbA mutant AD188 (data not shown).
To assess the impact of DsbA on virulence, strain
Newman and its dsbA defective derivative AD22 were
tested in a Caenorhabditis elegans killing assay (Sifri
et al. 2003). There was no signiﬁcant diﬀerence between
wild type and mutant strain, neither with respect to
killing rate, nor killing kinetics (C.D. Sifri, unpublished
results). The same strains were also tested in a mouse
model for septic arthritis (Bremell et al. 1991). The
severity of arthritis, weight decrease and mortality were
monitored over a period of 13 days, but no notable
diﬀerence was observed between Newman and AD22
(I.M. Jonsson, unpublished results).
Discussion
The family of DsbA proteins is known to constitute the
primary catalyst of protein disulﬁde bond formation in
Gram-negative bacteria (reviewed in Kadokura et al.
2003). Members of the DsbA family have been associ-
ated in Gram-negatives with pathogenicity and penicillin
resistance (Missiakas et al. 1993; Yu and Kroll 1999).
With the exception of the Bdb proteins of the genus
Bacillus (Ishihara et al. 1995; Bolhuis et al. 1999; Erl-
endsson and Hederstedt 2002), nothing is known about
how disulﬁde bond formation is accomplished by Gram-
positives. We have identiﬁed a potential DsbA homo-
logue in the human pathogen S. aureus. This is of
particular interest, since the active forms of various
staphylococcal virulence factors, such as enterotoxins
and beta-haemolysin, require disulﬁde bond formation
(Hovde et al. 1994; Dziewanowska et al. 1996). The lo-
calisation of SaDsbA as a membrane-anchored lipo-
protein supports a putative role in disulﬁde bond
formation of excreted virulence factors.
Heterologous complementation of an E. coli dsbA
mutant demonstrated that SaDsbA had in fact a func-
tional thiol-disulﬁde oxidoreductase activity. Moreover,
the measured redox potential of SaDsbA was very sim-
ilar to that of E. coli DsbA, indicating that the puriﬁed
staphylococcal protein is strongly oxidative. However,
the apparent lack of a phenotype, either in vitro or in
animal infection models, leaves the role of SaDsbA in S.
aureus open.
Despite its predominant transcription during expo-
nential growth, Western blot analysis demonstrated the
presence of SaDsbA throughout the growth. This indi-
cated that SaDsbA showed a rather long half-life and
that it might interact with surface associated, as well as
excreted proteins, which are predominantly produced by
S. aureus during the exponential and stationary growth
phases, respectively. The anchoring of SaDsbA to the
membrane is unusual for the oxidative members of the
DsbA family, which are generally secreted through the
Sec pathway and cleaved by signal peptidase I, resulting
in soluble periplasmic proteins (Schierle et al. 2003).
However, recently Tinsley and co-workers reported that
two of the three DsbA homologues produced by the
Gram-negative pathogen Neisseria meningitidis are
associated with the inner membrane via a lipoprotein
anchor (Tinsley et al. 2004). The particularity of nei-
sseria to secrete toxin-ﬁlled outer-membrane vesicles
(Pettit and Judd 1992) was postulated to lead to the loss
of periplasmic enzymes, in particular the non-mem-
brane-associated DsbA homologue (Tinsley et al. 2004).
Gram-positive bacteria, missing an outer-membrane,
have to prevent the diﬀusion of critical enzymes. A
thick, almost impermeable cell wall deﬁning a pseudo-
periplasm, as in B. subtilis, could compensate for the
lack of it (Merchante et al. 1995). B. brevis, whose DsbA
homologue Bdb is predicted to have a cleavable signal
sequence (Ishihara et al. 1995), probably makes use of
this diﬀusion barrier. An alternative strategy to prevent
diﬀusion of secreted proteins is anchoring them to the
membrane via a lipoprotein anchor or a transmembrane
anchor, as postulated for BdbD of B. subtilis (Erlends-
son and Hederstedt 2002). Lipoproteins of Gram-posi-
tive bacteria have been proposed to constitute the
functional equivalent of Gram-negative periplasmic
proteins (Nielsen and Lampen 1982), which may be the
case for SaDsbA.
In E. coli, re-oxidation of DsbA is achieved by the
action of DsbB (Guilhot et al. 1995; Kishigami et al.
1995; Kishigami and Ito 1996), and in B. subtilis, BdbD
is re-oxidised by BdbC (Erlendsson and Hederstedt
2002).
The experimental results of the present study strongly
suggest that the E. coli DsbB was not able to re-oxidise
SaDsbA. However, further biochemical experiments
would be required to deﬁnitely conﬁrm the lack of
Fig. 8 Complementation of the motility of an E. coli dsbA dsbB
double mutant. Where indicated (+Cys), cystine was added at a
concentration of 25 lg/ml
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interaction between those two proteins. The absence of
any DsbB or BdbC homologue, however, indicates that
the re-oxidation of the staphylococcus DsbA may be
carried out diﬀerently. A BLAST search through all
sequenced bacterial genomes revealed that a large
majority of species encoding a DsbA/BdbD homologue
also harbour a DsbB/BdbC homologue. Notable
exceptions besides S. aureus and S. epidermidis were the
insect symbionts Buchnera aphidicola and Wiggleswor-
thia glossinidia. Both organisms feature very small ge-
nomes (616 respectively 697 kb) that resulted from
reductive genome evolution as a consequence of their
endosymbiotic life forms (Akman et al. 2002; van Ham
et al. 2003). Neither function nor activity of DsbA in
these organisms are established, but the fact that the
gene has been conserved while hundreds of others were
discarded by the evolution speaks for its importance.
Additionally, it suggests that some bacteria may use a
diﬀerent way to re-oxidise DsbA. The di-amino acid
cystine for instance was shown to relieve the phenotype
of an E. coli mutant lacking dsbB at concentrations as
low as 20.8 lM (Dailey and Berg 1993). Interestingly,
cystine is present at a concentration of 40 lM in human
plasma (Chawla et al. 1984; Jones et al. 2000). Since S.
aureus is a human pathogen and is therefore often in
contact with blood plasma, cystine might contribute to
the re-oxidation of SaDsbA under such conditions.
Another potential redox partner of SaDsbA could be
SA2198. Since no homologue of SA2198 has been found
outside the Staphylococcus genus, it is currently not
feasible to estimate its function. The ﬁndings that dsbA
and SA2198 are co-transcribed, the similar genetic
organisation in S. epidermidis, and that SA2198 is pre-
dicted to be localised in the same cellular compartment
as SaDsbA, support the possibility that both proteins
are functionally linked. However, the lack of cysteine
residues in SA2198, which are essential for DsbB activity
(Guilhot et al. 1995), and the observation that plasmid
pAD2, containing SA2198 -dsbA, was not more eﬃcient
at restoring the motility of the E. coli mutants than
plasmid pAD11, encoding only SaDsbA, seemed to ex-
clude a DsbB-like action of SA2198 on SaDsbA.
In conclusion, despite its low sequence similarity to E.
coli DsbA, and being a membrane anchored protein, the
staphylococcal DsbA can functionally replace E. coli
DsbA. SaDsbA is thus the ﬁrst S. aureus protein shown
to have the potential for extracellular disulﬁde bond
formation. The ﬁnding that S. aureus, as well as some
other bacteria, encode a DsbA but lack a DsbB homo-
logue, leads us to postulate the existence of an alterna-
tive disulﬁde formation pathway distinct from the
classical DsbA–DsbB electron cascade. The exact func-
tion of SaDsbA in staphylococci, and its importance for
virulence of the human pathogens S. aureus and
S. epidermidis remains to be elucidated.
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